Literature DB >> 11730894

Copper-nuclease efficiency correlates with cytotoxicity for the 4-methoxypyrrolic natural products.

M S Melvin1, K E Wooton, C C Rich, G R Saluta, G L Kucera, N Lindquist, R A Manderville.   

Abstract

The DNA-targeting activities of the 4-methoxypyrrolic natural products, that include prodigiosin (1), tambjamine E (2), and the blue pigment (3), have been compared using fluorescence spectroscopy to study DNA binding and agarose gel electrophoresis to assess their ability to facilitate oxidative copper-promoted DNA cleavage. Fluorescence emission titration of 3 with calf-thymus DNA (CT-DNA) shows that the natural product occupies a site size (n) of ca. two base pairs and possesses an affinity constant (K) of approximately 6x10(5) x M(-1). Similar to prodigiosin (1), the blue pigment 3 was found to facilitate oxidative double-strand DNA (dsDNA) cleavage without the aid of an external reducing agent. Quantitation of ds- (n2) and ss- (n1) breaks provided n1:n2 ratios of approximately 8-12, which were significantly greater than the number expected from the accumulation of ss-breaks (approximately 120). This was contrasted by the nicking activity of tambjamine E (2), which only generates ss-breaks in the presence of copper. The superior copper-nuclease activity of 1 and 3 also correlated with their superior anticancer properties against leukemia (HL-60) cells. These results are discussed with respect to the mode of cytotoxicity by the 4-methoxypyrrolic natural products.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11730894     DOI: 10.1016/s0162-0134(01)00338-5

Source DB:  PubMed          Journal:  J Inorg Biochem        ISSN: 0162-0134            Impact factor:   4.155


  8 in total

1.  Proteomic analysis of prodigiosin-induced apoptosis in a breast cancer mitoxantrone-resistant (MCF-7 MR) cell line.

Authors:  Marta Monge; Marta Vilaseca; Vanessa Soto-Cerrato; Beatriz Montaner; Ernest Giralt; Ricardo Pérez-Tomás
Journal:  Invest New Drugs       Date:  2007-02       Impact factor: 3.850

Review 2.  Marine Mollusk-Derived Agents with Antiproliferative Activity as Promising Anticancer Agents to Overcome Chemotherapy Resistance.

Authors:  Maria Letizia Ciavatta; Florence Lefranc; Marianna Carbone; Ernesto Mollo; Margherita Gavagnin; Tania Betancourt; Ramesh Dasari; Alexander Kornienko; Robert Kiss
Journal:  Med Res Rev       Date:  2016-12-07       Impact factor: 12.944

Review 3.  Bioactive Compounds from Marine Heterobranchs.

Authors:  Conxita Avila; Carlos Angulo-Preckler
Journal:  Mar Drugs       Date:  2020-12-21       Impact factor: 5.118

4.  Isolation and characterization of tambjamine MYP1, a macrocyclic tambjamine analogue from marine bacterium Pseudoalteromonas citrea.

Authors:  Katherine J Picott; Julie A Deichert; Ella M deKemp; Gabriele Schatte; Françoise Sauriol; Avena C Ross
Journal:  Medchemcomm       Date:  2019-03-01       Impact factor: 3.597

5.  The carbon chain-selective adenylation enzyme TamA: the missing link between fatty acid and pyrrole natural product biosynthesis.

Authors:  Piera M Marchetti; Van Kelly; Joanna P Simpson; Mairi Ward; Dominic J Campopiano
Journal:  Org Biomol Chem       Date:  2018-04-18       Impact factor: 3.876

6.  Investigating Alkylated Prodigiosenes and Their Cu(II)-Dependent Biological Activity: Interactions with DNA, Antimicrobial and Photoinduced Anticancer Activity.

Authors:  Sebastian Doniz Kettenmann; Matthew White; Julien Colard-Thomas; Matilda Kraft; Andrea T Feßler; Karin Danz; Gerhard Wieland; Sylvia Wagner; Stefan Schwarz; Arno Wiehe; Nora Kulak
Journal:  ChemMedChem       Date:  2021-12-22       Impact factor: 3.540

7.  Prodigiosin analogue designed for metal coordination: stable zinc and copper pyrrolyldipyrrins.

Authors:  Tsuhen M Chang; Sanhita Sinharay; Andrei V Astashkin; Elisa Tomat
Journal:  Inorg Chem       Date:  2014-07-10       Impact factor: 5.165

8.  Synthesis of N-acyl amide natural products using a versatile adenylating biocatalyst.

Authors:  Piera M Marchetti; Shona M Richardson; Noor M Kariem; Dominic J Campopiano
Journal:  Medchemcomm       Date:  2019-05-31       Impact factor: 3.597

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.